NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/31/2023
Back to search
Official data from USPTO
CELLTRAPPER
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
56
Latest update
02/10/2024
Trademark type
Word
Nice classes
5
Filing date
08/09/2020
Registration date
10/31/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/31/2023
Last transaction
02/10/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
09/07/2023
First use in commerce
09/07/2023
Drawing code
4
Owner type
03
Owner location
Palo Alto, CA, US
Examiner
TARASCIO, MAUREEN J
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
VNRX Corp.
VNRX Corp.
Vincera Pharma, Inc.
Representatives
Patricia L. Cotton PILLSBURY WINTHROP SHAW PITTMAN LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of cancer; biologic preparations for the treatment of cancer
Publications
History of USPTO decisions and trademark events.
56 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
10/31/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09/29/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09/28/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/22/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/21/2023
EX4G
SOU EXTENSION 4 GRANTED
09/21/2023
IUAF
USE AMENDMENT FILED
09/19/2023
EXT4
SOU EXTENSION 4 FILED
09/19/2023
EEXT
SOU TEAS EXTENSION RECEIVED
09/19/2023
EISU
TEAS STATEMENT OF USE RECEIVED
09/19/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/24/2023
EX3G
SOU EXTENSION 3 GRANTED
03/22/2023
EXT3
SOU EXTENSION 3 FILED
03/22/2023
EEXT
SOU TEAS EXTENSION RECEIVED
03/22/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/02/2022
EX2G
SOU EXTENSION 2 GRANTED
11/30/2022
EXT2
SOU EXTENSION 2 FILED
11/30/2022
EEXT
SOU TEAS EXTENSION RECEIVED
11/30/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/16/2022
NOAC
CORRECTED NOA E-MAILED
03/16/2022
EX1G
SOU EXTENSION 1 GRANTED
03/15/2022
DPCC
DIVISIONAL PROCESSING COMPLETE
03/15/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/15/2022
EXT1
SOU EXTENSION 1 FILED
03/03/2022
DRRR
DIVISIONAL REQUEST RECEIVED
03/03/2022
EEXT
SOU TEAS EXTENSION RECEIVED
03/03/2022
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
03/03/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/21/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/26/2021
PUBO
PUBLISHED FOR OPPOSITION
10/26/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/06/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/20/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
09/20/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/20/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
09/20/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/20/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
09/19/2021
GNFR
FINAL REFUSAL E-MAILED
09/19/2021
CNFR
FINAL REFUSAL WRITTEN
09/19/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/26/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/26/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/19/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/06/2021
GNRT
NON-FINAL ACTION E-MAILED
08/06/2021
CNRT
NON-FINAL ACTION WRITTEN
08/06/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/15/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/15/2021
ALIE
ASSIGNED TO LIE
07/13/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/02/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/04/2020
GNRT
NON-FINAL ACTION E-MAILED
12/04/2020
CNRT
NON-FINAL ACTION WRITTEN
12/04/2020
DOCK
ASSIGNED TO EXAMINER
12/03/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/10/2020
NWAP
NEW APPLICATION ENTERED
08/12/2020
Continuous trademark protection
Get notified about every new filing that threatens CELLTRAPPER or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.